Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks

By Zacks Investment ResearchStock MarketsFeb 23, 2021 06:30AM ET
www.investing.com/analysis/cyclical-sectors-gain-momentum-in-early-2021-7-top-picks-200562626
Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks
By Zacks Investment Research   |  Feb 23, 2021 06:30AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Wall Street witnessed an impressive rally in 2020 defying coronavirus-induced economic devastations. The stock market's dream run continues in early 2021 too. While growth-oriented technology sector was the predominant driver behind last year's rally, cyclical sectors like consumer discretionary, industrials, materials, financials and oil-energy are the main sources of Wall Street's northbound journey so far this year.

Gradual reopening of the U.S. economy on the back of nationwide deployment of COVID-19 vaccines, a sharp rebound in aggregate consumer demand and recent spike in yields of sovereign government bonds have shifted investors' preference from growth stocks to cyclical stocks.

Cyclical Sectors Outperform Year to Date

A closer look at the performance of the S&P 500 Index — popularly known as the market's benchmark — so far this year reveals some interesting facts.

Cyclical sectors like Industrials Select Sector SPDR (XLI), Materials Select Sector SPDR (XLB), Financials Select Sector SPDR (XLF), Consumer Discretionary Select Sector SPDR (XLY) and Energy Select Sector SPDR (XLE (NYSE:XLE)) gained 3.1%, 3.7%, 9.9%, 3.3% and 21.9%, respectively. In contrast, the Technology Select Sector SPDR (XLK) has gained just 2.3%, underperforming the benchmark itself, which has advanced 3.2% year to date.

Reopening of U.S. Economy

The U.S. government has ramped up nationwide deployment of COVID-19 vaccines. Moreover, the news cases of coronavirus infections and hospitalization declined significantly this month. The combined effect of these two factors will be gradual reopening of the U.S. economy, which is operating at sub-optimal level since lockdowns were imposed last year. Notably, on Feb 1, the Congressional Budget Office (CBO) projected that the economy is expected to reach the pre-pandemic level of February 2020 by mid-2021.

Sharp (OTC:SHCAY) Rebound in Consumer Demand

The U.S. economy is witnessing strong consumer demand buoyed by massive fiscal and monetary stimulus injected in it. Moreover, the Democrats are moving forward with President Biden’s proposed $1.9 trillion COVID-19 relief package, which will further boost consumer demand.

Last week, Goldman Sachs reported that currently U.S. citizens have nearly $1.5 trillion in "excess" or "forced" savings that could climb to $2.4 trillion by mid-2021. The massive savings were due to concerns over pandemic-led economic uncertainties. Consumers were restrained or restricted by the government to spend on those items that were unavailable during lockdowns.

Reopening of the economy with massive savings is likely to boost personal spending, which in turn will raise demand for businesses, especially those in the cyclical sectors.

Spike in Sovereign Bond Yields

Wall Street's astonishing rally for the past 11 months prompted investors to shift the allotment of funds from safe-haven government bonds to risky equities. Consequently, on Feb 22, the yield on the benchmark 10-year US Treasury Note closed at 1.364% after hitting 1.377% in intraday trading, its highest since Feb 26, 2020. Furthermore, the yield on 30-year US Treasury Note ended at 2.181%, its highest since January 2020.

High risk-free return is detrimental to high growth industries like technology. Most of the growth companies depend on easy borrowing at cheap rates. Higher market interest rate will raise their cost of projects. As a result, market participants have started to reallocate their funds to cyclical stocks from growth stocks.

Our Top Picks

We have narrowed down our search to seven large-cap (market capital >$10 billion) cyclical stocks that have popped more than 10% year to date and still have upside left for 2021. These stocks have seen solid earnings estimate revisions in the past 30 days. Each of our picks carries either a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The chart below shows the price performance of our seven picks year to date.

Denbury Inc. DEN operates as an independent oil and natural gas company in the United States. It holds interests in various oil and natural gas properties located in Mississippi, Texas, and Louisiana in the Gulf Coast region; and in Montana, North Dakota and Wyoming in the Rocky Mountain region.

This Zacks Rank #1 company has expected earnings growth of more than 100% for the current year. The Zacks Consensus Estimate for its current-year earnings has increased 26.7% over the past 30 days. The stock price has soared 55.7% year to date.

Citizens Financial (NYSE:CFG) Group Inc. CFG operates as the bank holding company for Citizens Bank, National Association that provides retail and commercial banking products and services in the United States. It operates in two segments, Consumer Banking and Commercial Banking.

This Zacks Rank #1 company has an expected earnings growth rate of 53.5% for the current year. The Zacks Consensus Estimate for the current year has improved 13.1% over the past 30 days. The stock price has rallied 21% year to date.

The Goldman Sachs Group Inc (NYSE:GS).'s GS key source of earnings stability is its business diversification. Within traditional banking, a diversified product portfolio has better chances of sustaining growth than many other banks, which have exited some of these areas. It operates in four segments: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management.

This Zacks Rank #2 company has an expected earnings growth rate of 15.8% for the current year. The Zacks Consensus Estimate for the current year has improved 8.2% over the past 30 days. The stock price has climbed 19.9% year to date.

Axon Enterprise (NASDAQ:AXON) Inc. AXON develops, manufactures, and sells conducted energy weapons worldwide. It operates through two segments, TASER and Software and Sensors. This Zacks Rank #2 company has an expected earnings growth rate of 15.8% for the current year. The Zacks Consensus Estimate for the current year has improved 1.5% over the past 30 days. The stock price has jumped 38.8% year to date.

Caterpillar Inc (NYSE:CAT). CAT manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives worldwide. This Zacks Rank #2 company has an expected earnings growth rate of 21.3% for the current year. The Zacks Consensus Estimate for the current year has improved 4.5% over the past 30 days. The stock price has appreciated 19.3% year to date.

The Scotts Miracle-Gro Co Inc. SMG manufactures, markets and sells consumer lawn and garden products in the United States and internationally. The company operates through three segments: U.S. Consumer, Hawthorne and Other.

This Zacks Rank #1 company has an expected earnings growth rate of 21% for the current year (ending September 2021). The Zacks Consensus Estimate for the current year has improved 6.2% over the past 30 days. The stock price has risen 13.3% year to date.

Eastman Chemical Co. EMN operates as an advanced materials and specialty additives company worldwide that manufactures and sells chemicals, plastics and fibers. This Zacks Rank #2 company has an expected earnings growth rate of 28.1% for the current year. The Zacks Consensus Estimate for the current year has improved 7.9% over the past 30 days. The stock price has advanced 13.2% year to date.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report

Caterpillar Inc. (CAT): Get Free Report

Eastman Chemical Company (NYSE:EMN): Free Stock Analysis Report

The Scotts MiracleGro Company (SMG): Get Free Report

Citizens Financial Group, Inc. (CFG): Free Stock Analysis Report

Axon Enterprise, Inc (AXON): Get Free Report

Denbury Inc. (DEN): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research
Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks
 

Related Articles

Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email